|
Volumn 31, Issue 4, 2008, Pages
|
Can guideline adherence be improved by letter outreach?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
CHOLESTEROL;
ABSENCE OF SIDE EFFECTS;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG SAFETY;
FOLLOW UP;
HEART PROTECTION;
HUMAN;
LABORATORY TEST;
LETTER;
PATIENT SAFETY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIMARY MEDICAL CARE;
PROSPECTIVE STUDY;
ADOLESCENT;
AGED;
BLOOD;
HEART DISEASE;
MIDDLE AGED;
PATIENT COMPLIANCE;
UNITED STATES;
WRITING;
ADOLESCENT;
AGED;
AGED, 80 AND OVER;
CHOLESTEROL;
COLORADO;
CORRESPONDENCE AS TOPIC;
DIABETES MELLITUS;
HEART DISEASES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MIDDLE AGED;
PATIENT COMPLIANCE;
|
EID: 48649088283
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc07-1661 Document Type: Letter |
Times cited : (5)
|
References (5)
|